16 September 2016 - PM Live reports the new scheme proposes a single payment mechanism for new and old medicines.
The UK has set out its stall for controlling the cost of branded medicines, which focuses on introducing a single payment mechanism for both new and old drugs.
The proposed scheme would replace the current 15% price reduction on drugs on sale on 1 December 2013 with a blanket payment by companies against eligible sales of all drugs - proposed as a 10% to 17% range - after deducting discounts and VAT.